Cargando…
Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region
Lung cancer remains a major cause of cancer mortality with a 5-year survival in advanced stages around 4%. Platinum-based chemotherapy was routinely used as the standard of care in patients with advanced nonsmall cell lung cancer, but it is being progressively replaced by targeted molecular therapy....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611202/ https://www.ncbi.nlm.nih.gov/pubmed/31333766 http://dx.doi.org/10.4103/atm.ATM_344_18 |